(MENAFN- Liker Series) Compare all common treatments for COVID-19 for which studies have been published over the past four years, according to the WHO Minimum Common Outcome Measures established for COVID-19 clinical research. A peer-reviewed study was published. The study not only looked at allopathic conventional coronavirus treatments such as FDA and ICMR-approved faviavipir and remdesivir, but also examined Ayurvedic, Siddha, herbal, homeopathic, African and traditional coronavirus treatments. We also investigated traditional Chinese medicine treatments for the new coronavirus. We also investigated and compared studies conducted on HCQ I (hydroxychloroquine) and ivermectin, which are popular for off-label use in COVID-19. The published study is relevant as news about vaccine side effects has led some manufacturers, like AstraZeneca, to take the vaccine off the market and put the need for safe and effective treatments back in the spotlight. It is relevant and timely. The world needs and will continue to need effective treatment protocols for COVID-19. This study provides a clear plan of action if infected.
The study looks at both individual randomized clinical trials and big data about the coronavirus. They found that cultures using traditional medical systems had lower mortality rates. It has also been found that natural medicine is generally more effective than pharmaceuticals in treating coronavirus infections. One trial in particular that stands out is the WHO database-approved trial of Reginmune and Immunofree. The combination of these two products showed one of the best results worldwide, as 88% of moderately ill patients who participated in the trial tested negative on his fifth day. Reginmune is a European-designed immunomodulator that contains a variety of vitamins, minerals, and amino acids. Immunofree is an Ayurvedic therapy created in India and specifically designed for the coronavirus. It contains specific herbs intended to: It lyses viral membranes, breaks down the bonds that viruses make with cells, builds new bodies, balances cellular immunity, expands the lungs, fights inflammation and clotting, and blocks cytokine storms. BiogeticaUSA, the manufacturer of these products, is currently considering running an immunofree trial to reduce adverse events of the vaccine, including long-term COVID-19 side effects and blood clots. This comparative study is therefore an excellent guide for physicians of all traditions who are interested in treating their patients with the best possible care. In some ways, this is a major victory for those who have been fighting to restore respect for natural medicine. Additionally, Ivermectin, which is very popular today, has limited research to back it up and was also found to be less effective than the natural medicines mentioned above.
This comparative study was conducted by Dr. Supriya Bhalerao and Dr. Vedvati Bhapkar, eminent doctors and researchers from Bharati Vidyapeeth University and Padmashree Di Patil University, and was published in the International Journal of Ayurvedic Medicine . It has since been reprinted in many journals and research portals.
MENAFN12052024005698012489ID1108202026
Legal disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
